PPT-Anticholinergic burden program

Presentation Template NPS MedicineWise Anticholinergic burden What comes to mind Anticholinergic burden an important QUM issue Anticholinergic burden is the cumulative effect on a person from taking one or more medicines with anticholinergic effects. 1 Epidemiology and Burden of Disease WHO Geneva (EBD/GPE) 2 Dmaternal sepsisft 15 Global Burden of Disease 2000 By . Dr.. . Anjeannette. Reece. Introduction. AAPCC . National Poison Data System Annual Report . (2007). 1. :. 8. 8,582 . single exposures to anticholinergic . drugs. Unintentional . ingestions . – 83,352 . Denning . DW. 1. , Pegorie M. 2. , . Welfare . W. 2. ,3. 24th European Congress of Clinical Microbiology and Infectious Diseases in Barcelona, . Spain, May 2014. 1. National . Aspergillosis. Centre, University Hospital of South Manchester and The University of Manchester, Manchester . Kathleen McNamara, . PharmD. PGY1 Pharmacy Resident 2015-2016 NEIMEF & WHC. Therapy Goals & Assessment. Non-pharmacologic & Pharmacologic Therapy. Medications. Mechanism of Action. Adverse Effects. By: Cassandra Kessler. PHIL 1100. Critical Thinking. Misplacing the Burden of Proof. Definition: a type of fallacy that occurs when a speaker or writer attempts to support or prove a point by trying to make us disprove it. Major Depressive . Disorder. (MDD). Depression is a chronic, recurring, and progressive disorder affecting . 300-350 million . people worldwide. 1,2. Depression is a highly prevalent disorder. The percentage of people suffering from MDD worldwide was . or . Antimuscarinic. Agents. Definintion. :. Drugs which inhibit the actions of acetylcholine on structures innervated by postganglionic cholinergic nerves and on smooth muscle cells that respond to acetylcholine but lack cholinergic . 1 Epidemiology and Burden of Disease WHO Geneva GPE/EBD 2 Prevention of Blindness and Deafness MNC/PBD WHO Geneva 3 Ministry of Health Chile 2 Global Burden of Disease 2000 Table 22 summarizes the syndrome (CAS). Dr. S. . Parthasarathy. . MD., DA., DNB, MD (. Acu. ), Dip. . Diab. . DCA, Dip. Software . statistics,Ph. D (physiology) . Mahatma . gandhi. medical college and research institute, . Anticholinergic:. Poisoning with these drugs is less common than it was in former years. Because these drugs are not used as frequently in drug therapy. Ex.. Belladonna alkaloids and related atropine- like drugs have been replaced with a different class of less toxic drugs H. DB00021 . Protein chemical . formula . : C. 130. H. 219. N. 43. O. 42. Protein . average . weight : . 3056.4000. Chemical name : . H-His-Ser-Asp-. Gly. -. Thr. -. Phe. -. Thr. -Ser-. Glu. -. Leu. -Ser-. 1. Migraine. Migraine epidemiology. An estimated 1.3 billion individuals across the globe were estimated to have migraine in 2017. 1. In the WHO Global Burden of Disease study, ‘headache disorders’ has consistently been the 2. MacFeely. Director of Business Statistics & Innovation. Outline of Presentation. 1. CSO . 2. Burden Reduction. 3. Costs. 4. Blockages & Risks. CSO - Mandate. Statistics Act, 1993. To collect, compile, extract and disseminate for statistical purposes, information . f. Hanan H. agar. Pharmacology Unit. Medical College. King Saud University. What students should know:. Student should be able to : . . Identify the classification of anticholinergic drugs. Describe pharmacokinetics and dynamics of muscarinic antagonists .